Labcorp is offering retinal imaging at patient service centers for diabetic patients

Helping you provide better patient care

Labcorp, a leading global life sciences company that provides comprehensive clinical laboratory services, is teaming up with Wills Eye Hospital, a world-renowned leader dedicated to improving and preserving sight, Independence Blue Cross, a leading health insurance company in the Philadelphia region, and Keystone First, Pennsylvania's largest medical assistance (Medicaid) managed care health plan, to bring awareness to diabetic retinopathy.

 WillsEye Hospital       KF       Keystone First VIP ChoiceIndependence Blue Cross

Labcorp Screening

  • Labcorp is performing diabetic retinopathy retinal screening at select patient service centers in the Philadelphia area.
  • This service is only available to patients with with Independence Blue Cross or Keystone First insurance.
  • A licensed board certified ophthalmic retinal specialist of Wills Eye Hospital will interpret the report.

* The ADA states that although retinal photography may be used to screen for retinopathy, it should not be a substitute for a comprehensive eye exam.1

Diabetic Retinal Imaging Checklist:Zeiss-Visuscout

  1. Physician must have a Labcorp account number.
  2. This service is only available to patients with Independence Blue Cross or Keystone First insurance.
  3. Order Labcorp test no. 830285, Diabetic Retinopathy Imaging.
  4. Patients may schedule an appointment at one of the three listed PSCs.
  5. Retinal images from the screening are sent remotely to Wills Eye Hospital for analysis.
  6. Ordering physicians will receive a retinal report interpreted by a licensed board-certified Opthalmic retinal specialist of Wills Eye Hospital.

Patients may schedule an appointment with an order from a physician for retinal imaging without eye dilation at the following PSCs:

  • 1120 Township Line Rd., 1st Floor, Havertown, PA 19083; Phone: 610-352-3262

  • 15200 Bustleton Ave., Philadelphia, PA 19136; Phone: 215-437-7970

  • 3790 Morrell Ave., Philadelphia, PA 19114; Phone: 267-538-3598

If you would like more information on this program, please enter your information and a Labcorp sales representative will contact you.

References

  1. American Diabetes Association (2018). Standards of medical care in diabetes – 2018. Diab. Care, 41(Suppl. 1), S1–S2. 10.2337/dc18-SINT01​
  2. The Endocrine Society. Endocrine facts and figures: Diabetes. First edition. 2015.

LabCorp, Wills Eye Hospital, Independence Blue Cross and Keystone First are collaborating to raise awareness about the risk of diabetic retinopathy. LabCorp and Wills Eye Hospital are independent health care providers, do not provide joint patient care and are not legally affiliated in any way. Independence Blue Cross and Keystone First are health insurance providers and are not legally affiliated with LabCorp or Wills Eye Hospital.

The American Diabetes Association (ADA) recommends diabetic retinopathy (DR) screening for patients with type 1 and type 2 diabetes.1

Eye exam image

  • Over 29 million Americans have diabetes.2
  • For every 100 Americans diagnosed with diabetes: 29-33 have retinopathy.2
  • In developed countries, DR is the most frequent cause of new cases of blindness among adults age 20-74.1

Screening for diabetic retinopathy may help prevent loss of vision by allowing intervention with treatment when vision loss can be prevented, or reversed.1

Scroll back to top of page